Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSD11B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KMT2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
KAT6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIRT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102724094 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR1306 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YAF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SF3A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRCAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PACS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
URGCP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APLP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCO6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on